Mediolanum International Funds’s Gilead Sciences GILD Stock Holding History

Mediolanum International Funds’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.32M	Sell	50,027 -109,524	-69%	-$14.4M	0.05%	272
2026 Q1	$21.8M	Sell	159,551 -2,198	-1%	-$308K	0.23%	109
2025 Q4	$19.9M	Sell	161,749 -28,054	-15%	-$3.41M	0.2%	132
2025 Q3	$21.4M	Buy	189,803 +9,971	+6%	+$1.13M	0.22%	109
2025 Q2	$19.9M	Buy	179,832 +82,402	+85%	+$8.77M	0.24%	103
2025 Q1	$10.9M	Buy	97,430 +39,520	+68%	+$4.08M	0.15%	152
2024 Q4	$5.32M	Sell	57,910 -3,752	-6%	-$338K	0.07%	232
2024 Q3	$5.15M	Sell	61,662 -89,617	-59%	-$6.84M	0.07%	240
2024 Q2	$9.72M	Buy	151,279 +88,387	+141%	+$5.9M	0.16%	133
2024 Q1	$4.59M	Buy	+62,892	New	+$4.84M	0.07%	231

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mediolanum International Funds's GILD Position: Q2 2026 in Review

Mediolanum International Funds reduced its Gilead Sciences (GILD) stake by 69% in Q2 2026, selling an estimated $14.4M and leaving 50,027 shares worth $6.32M. The position accounts for 0.05% of the portfolio, ranked #272.

Mediolanum International Funds first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $21.8M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Mediolanum International Funds held 50,027 shares of Gilead Sciences worth $6.32M as of Q2 2026.
Mediolanum International Funds sold 109,524 Gilead Sciences shares in Q2 2026, an estimated $14.4M.
Gilead Sciences made up 0.05% of Mediolanum International Funds's portfolio in Q2 2026, its #272 holding.
Mediolanum International Funds first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
Mediolanum International Funds's Gilead Sciences position peaked at $21.8M in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.